Logo image of MEDP

MEDPACE HOLDINGS INC (MEDP) Stock Analyst Earnings Estimates

NASDAQ:MEDP - Nasdaq - US58506Q1094 - Common Stock - Currency: USD

350.04  +7.02 (+2.05%)

After market: 350.04 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
MEDP revenue by date.MEDP revenue by date.
1.142B
23.38%
1.46B
27.80%
1.886B
29.17%
2.149B
13.95%
2.271B
5.68%
2.546B
12.11%
2.876B
12.96%
3.274B
13.84%
3.603B
10.05%
4.058B
12.63%
4.562B
12.42%
5.127B
12.38%
EBITDA
YoY % growth
MEDP ebitda by date.MEDP ebitda by date.
219.7M
17.74%
301.1M
37.05%
363.153M
20.61%
470.27M
29.50%
489.23M
4.03%
551.33M
12.69%
628.65M
14.02%
747.37M
18.88%
831.73M
11.29%
945.38M
13.66%
1.072B
13.39%
1.216B
13.43%
EBIT
YoY % growth
MEDP ebit by date.MEDP ebit by date.
198.6M
18.92%
278.7M
40.33%
336.825M
20.86%
439.28M
30.42%
457.97M
4.25%
521.97M
13.97%
592.73M
13.56%
708.56M
19.54%
788.55M
11.29%
898.8M
13.98%
1.023B
13.82%
1.163B
13.69%
Operating Margin
MEDP operating margin by date.MEDP operating margin by date.
17.38%19.09%17.86%20.44%20.17%20.50%20.61%21.64%21.89%22.15%22.42%22.68%
EPS
YoY % growth
MEDP eps by date.MEDP eps by date.
4.81
22.70%
7.32
52.18%
8.88
21.31%
12.18
37.19%
12.80
5.09%
14.71
14.91%
16.68
13.40%
18.72
12.20%
21.13
12.92%
23.77
12.48%
26.74
12.49%
30.03
12.32%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
3.02
22.62%
3.06
-4.32%
3.06
11.41%
3.20
6.41%
3.30
9.41%
3.54
15.76%
3.49
13.77%
3.70
15.44%
3.87
17.14%
Revenue
Q2Q % growth
545.49M
9.45%
548.17M
7.26%
558.85M
5.82%
571.9M
7.23%
586.16M
7.46%
610.01M
11.28%
632.63M
13.20%
655.24M
14.57%
674.33M
15.04%
EBITDA
Q2Q % growth
117.68M
3.55%
116.7M
5.08%
117.79M
-1.33%
123.55M
-7.81%
126.44M
7.44%
132.19M
13.27%
132.49M
12.48%
140.4M
13.64%
145.81M
15.32%
EBIT
Q2Q % growth
110.21M
26.21%
109.41M
5.13%
109.79M
4.41%
114.49M
1.97%
118.38M
7.41%
124.14M
13.46%
124.26M
13.18%
131.99M
15.29%
137.2M
15.90%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
3.01
35.59%
2.830.186.19%
Q2 2024
Q2Q % growth
2.75
42.49%
2.590.166.29%
Q1 2024
Q2Q % growth
3.20
40.97%
2.510.6927.27%
Q4 2023
Q2Q % growth
2.46
16.04%
2.270.198.54%
Q3 2023
Q2Q % growth
2.22
8.29%
2.090.136.38%
Q2 2023
Q2Q % growth
1.93
32.19%
1.95-0.02-1.18%
Q1 2023
Q2Q % growth
2.27
34.32%
1.840.4323.57%
Q4 2022
Q2Q % growth
2.12
60.61%
1.820.3016.37%
Q3 2022
Q2Q % growth
2.05
58.91%
1.500.5536.37%
Q2 2022
Q2Q % growth
1.46
37.74%
1.340.129.10%
Q1 2022
Q2Q % growth
1.69
48.25%
1.290.4031.39%
Q4 2021
Q2Q % growth
1.32
-2.22%
1.280.043.45%
Q3 2021
Q2Q % growth
1.29
18.35%
1.100.1917.78%
Q2 2021
Q2Q % growth
1.06
55.88%
1.010.055.01%
Q1 2021
Q2Q % growth
1.14
42.50%
1.020.1211.36%
Q4 2020
Q2Q % growth
1.35
58.82%
1.270.086.66%
Q3 2020
Q2Q % growth
1.09
53.52%
1.10-0.01-0.48%
Q2 2020
Q2Q % growth
0.68
-16.05%
0.420.2661.20%
Q1 2020
Q2Q % growth
0.80
25.00%
0.760.044.92%
Q4 2019
Q2Q % growth
0.85 0.770.0810.57%
Q3 2019
Q2Q % growth
0.71 0.73-0.02-2.35%
Q2 2019
Q2Q % growth
0.81 0.650.1625.02%
Q1 2019
Q2Q % growth
0.64 0.610.034.48%
MEDP Yearly EPS VS EstimatesMEDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
533.317M
8.29%
551.81M-18.493M-3.35%
Q2 2024
Q2Q % growth
528.104M
14.59%
539.19M-11.086M-2.06%
Q1 2024
Q2Q % growth
511.044M
17.72%
522.84M-11.796M-2.26%
Q4 2023
Q2Q % growth
498.401M
26.47%
508.69M-10.289M-2.02%
Q3 2023
Q2Q % growth
492.499M
28.36%
485.27M7.229M1.49%
Q2 2023
Q2Q % growth
460.868M
31.23%
442.37M18.498M4.18%
Q1 2023
Q2Q % growth
434.1M
31.19%
409.84M24.26M5.92%
Q4 2022
Q2Q % growth
394.1M
27.71%
393.73M370K0.09%
Q3 2022
Q2Q % growth
383.7M
29.80%
364.33M19.37M5.32%
Q2 2022
Q2Q % growth
351.2M
26.19%
350.9M300K0.09%
Q1 2022
Q2Q % growth
330.9M
27.27%
333.64M-2.74M-0.82%
Q4 2021
Q2Q % growth
308.6M
18.83%
315.22M-6.62M-2.10%
Q3 2021
Q2Q % growth
295.6M
28.30%
297.39M-1.79M-0.60%
Q2 2021
Q2Q % growth
278.3M
35.76%
277.54M760K0.27%
Q1 2021
Q2Q % growth
260M
12.60%
270.59M-10.59M-3.91%
Q4 2020
Q2Q % growth
259.7M
12.96%
250.88M8.82M3.52%
Q3 2020
Q2Q % growth
230.4M
6.57%
228.03M2.37M1.04%
Q2 2020
Q2Q % growth
205M
-4.25%
184.14M20.86M11.33%
Q1 2020
Q2Q % growth
230.9M
15.05%
230.5M400K0.17%
Q4 2019
Q2Q % growth
229.9M 226.17M3.73M1.65%
Q3 2019
Q2Q % growth
216.2M 221.48M-5.28M-2.38%
Q2 2019
Q2Q % growth
214.1M 205M9.1M4.44%
Q1 2019
Q2Q % growth
200.7M 194.14M6.56M3.38%
MEDP Yearly Revenue VS EstimatesMEDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B 5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 2.92% 0% 3.07%
Revenue0% -7.61% 0% -1.6%